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Chronic pathogens have evolved exquisite mechanisms of self-regulation via manipulation of host signaling
pathways; however, pathologic consequences may ensue. Tsugawa et al. (2012) now report a mechanism of
checks and balances used by Helicobacter pylori that is undermined by gastric stem cells, which may lower
the threshold for gastric cancer.The holiday season is typically a time of
great anticipation and excitement, fueled
by visits from old friends, colleagues,
and relatives. For many, however, the
process of reconnecting is time-limited;
how many times can we bear to hear the
same story or have our daily routines dis-
rupted? There is a finite point (which is
dependent onmultiple variables!) at which
prolonged visits can degenerate into
pathologic ones. In this issue of Cell
Host & Microbe, Tsugawa et al. (2012)
provide molecular insights into a similar
situation occurring within the stomach
that has the potential for deadly
consequences.
Gastric adenocarcinoma is the second
leading cause of cancer-related death
in the world, and gastritis induced by
Helicobacter pylori is the strongest known
risk factor for this malignancy (Wroblew-
ski et al., 2010). H. pylori colonizes the
stomach for years, not days or weeks as
is usually the case for other bacterial path-
ogens, and it always induces inflamma-
tion; however, only a fraction of colonized
individuals ever develop disease. As
might be predicted for a chronic path-
ogen, H. pylori has evolved several mech-
anisms to evade the host immune
response. The LPS ofH. pylori is relatively
anergic, exhibiting >3 log-fold less endo-
toxin activity when compared with LPS
from other Gram-negative bacteria
(Pe´rez-Pe´rez et al., 1995). Similarly, the
ability of H. pylori flagellin to activate
TLR5 pales in comparison to flagellin
from other mucosal pathogens (Gewirtz
et al., 2004).
An H. pylori strain-specific virulence
locus that augments cancer risk is the
cag pathogenicity island, which encodes
a type IV secretion system (TFSS) thatinjects microbial proteins into host cells.
The product of the cagA gene (CagA) is
translocated by the TFSS into epithelial
cells where it undergoes targeted tyrosine
phosphorylation by Src and Abl kinases
(Backert and Tegtmeyer, 2010), leading
to morphological aberrations that mirror
changes induced by growth factor stimu-
lation. Nonphosphorylated CagA also
induces effects with carcinogenic poten-
tial, including activation of b-catenin
(Franco et al., 2005). Another bacterial
factor, which is evolutionarily linked to
the presence of cagA and associated
with H. pylori-induced disease, is the
vacuolating cytotoxin VacA. VacA is an
approximately 140 kDa protein that
undergoes proteolytic cleavage to yield
an 88 kDa product that can be further
cleaved to 33 kDa and 55 kDa fragments
that assemble into large oligomeric
complexes. Unlike cagA, the gene encod-
ing VacA (vacA) is found in all strains at
a distinct site on the H. pylori chromo-
some, but exists as allelic variants that
elicit different epithelial cell responses.
Polymorphic sites exist within the signal
(s) region, the mid (m) region, and the
more recently identified intermediate (i)
region, and vacA s1/m1/i1 variants are
more strongly associated with gastric
adenocarcinoma (Rhead et al., 2007).
VacA interacts with mitochondrial mem-
branes, leading to a decrease in mito-
chondrial transmembrane potential,
release of cytochrome c, and induction
of apoptosis. However, pioneering work
from the group of Nicola Jones has deter-
mined that VacA can also trigger another
intracellular pathway, autophagy, which
is required for protein degradation and
elimination of microbial pathogens (Tere-
biznik et al., 2009).Cell Host & Microbe 12, DRecent studies have indicated that
there are numerous checks and balances
in place to legislate CagA- and VacA-
dependent cellular consequences. In
Mongolian gerbils, CagA activates a cell
survival pathway mediated by the MAPK
ERK and induces expression of the antia-
poptotic protein MCL1 in gastric pit cells
(Backert and Tegtmeyer, 2010). Further,
unphosphorylated CagA antagonizes
VacA-induced apoptosis at themitochon-
drial membrane while phosphorylated
CagA hinders VacA from reaching tar-
geted intracellular compartments. These
data suggest a model in which VacA has
a role in colonization of the gastric niche,
but after colonization is established, its
activity is modulated by translocated
CagA, favoring bacterial persistence and
protection against cellular apoptosis.
Other examples of VacA and CagA
counter-regulation include NFAT activa-
tion (activated by CagA, inhibited by
VacA), epidermal growth factor receptor
signaling (activated by CagA, inhibited
by VacA), and induction of aberrant
cellular morphology (VacA negatively
regulates CagA-induced cell elongation;
CagA inhibits VacA-induced vacuolation)
(Backert and Tegtmeyer, 2010). These
observations provided the framework for
the current study.
Tsugawa et al. (2012) began with the
fundamental observation that levels of
intracellular CagA decreased over time
in both gastric epithelial cells infected
with viable H. pylori and within an induc-
ible CagA-expressing gastric epithelial
cell system. Manipulating these systems
with chemical inhibitors of autophagy
allowed the authors to determine that
degradation of CagA was mediated by
the autophagy pathway. These findingsecember 13, 2012 ª2012 Elsevier Inc. 733
Figure 1. Schematic Representation of the Fate of Intracellular CagA
(A) In non-CD44v9-expressing gastric epithelial cells, intracellular CagA is degraded via autophagy.
VacA m1 binding to low-density lipoprotein receptor-related protein-1 (LRP1) depletes glutathione
(GSH) and, along with accumulation of intracellular reactive oxygen species (ROS), leads to phosphoryla-
tion of Akt, which in turn phosphorylates murine double minute 2 (MDM2) and enhances MDM2-mediated
p53 degradation via ubiquitination. Degradation of p53 unleashes autophagy with the resulting elimination
of CagA.
(B) CD44v9-expressing cancer stem-like cells fail to deplete GSH and are resistant to ROS, and CagA
degradation by autophagy is subsequently suppressed, permitting accumulation of translocated CagA
and lowering the threshold for carcinogenesis.
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implicating VacA in the induction of auto-
phagy (Terebiznik et al., 2009), and the
results demonstrated that binding of the
VacA m1 region to a specific receptor on
the epithelial cell surface, LRP1, triggered
autophagy-mediated elimination of CagA.
Based on previous observations (Bhatta-
charyya et al., 2010), the molecular steps
linking VacA-LRP1 binding and auto-
phagy were then filled in via inhibitor
studies that focused on activation of reac-
tive oxygen species (ROS), and a working
model was constructed as follows: inter-
actions between VacA m1 and LRP1
lead to reduced levels of glutathione,
increased Akt phosphorylation, enhanced
MDM2-mediated p53 degradation, and
activation of autophagy (Figure 1). In and
of itself, delineation of this pathway repre-
sents a true tour de force which inextri-
cably links VacA and CagA again as
proteins that can exert opposing forces
on the host. However, Tsugawa et al.
(2012) took their work a step further by734 Cell Host & Microbe 12, December 13, 20demonstrating that gastric epithelial cells
that express a stemness marker, CD44
variant9 (CD44v9), and which are resis-
tant to the effects of ROS, fail to degrade
CagA. Thus, a subpopulation of host cells
with progenitor-like features are uniquely
susceptible to the effects of the microbial
oncoprotein CagA, which may lower their
threshold for carcinogenesis.
This study is important as it forces
investigators focused on gastric carcino-
genesis to reconsider previously held
beliefs. For example, many studies have
concluded that generation of ROS by
H. pylori is detrimental to the host; the
current findings suggest that ROS may
be beneficial by dampening the effects
of CagA within epithelial cells. Progres-
sion to gastric cancer in humans occurs
within an inflammatory milieu. Subse-
quent studies should therefore focus on
the role of the host immune response in
regulating H. pylori-induced autophagy.
It will be critical to determinewhich gastric
epithelial cell lineages harbor intracellular12 ª2012 Elsevier Inc.CagA during infection in vivo and whether
cells with stem-like features are more
or less susceptible to CagA transloca-
tion. What is the biological function of
intracellular CagA? Recent studies have
suggested that translocation of CagA
may facilitate iron acquisition from the
host (Tan et al., 2011); are there other
benefits for the microbe or the host
that are conferred by intracellular delivery
of CagA? In sum, the findings from this
study are important, not only for under-
standing the development of gastric
cancer but also because the insights
derived may be applicable to other malig-
nancies that arise in the context of micro-
bial infections.
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